Clinical Trial

FebriDx® Pediatric Validation Study

Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to determine performance characteristics of the FebriDx® test in differentiating bacterial from non-bacterial etiology among febrile pediatric patients (2-11 years) presenting to the emergency department, urgent care center or primary care office with a suspected acute respiratory tract infection.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-10-01; most recent amendment 2026-07-02.
Status change: Not Yet Recruiting → Recruiting 2025-10-30
Trial Details
NCT Number NCT07211997
Lead Sponsor Lumos Diagnostics
Conditions Acute Respiratory Infections (ARIs)
Enrollment 800 participants
Start Date 2025-10-09
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-07